SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Seftel Matthew D.)
 

Search: WFRF:(Seftel Matthew D.) > (2014) > Allotransplantation...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • McClune, Brian L. (author)

Allotransplantation for Patients Age >= 40 Years with Non-Hodgkin Lymphoma : Encouraging Progression-Free Survival

  • Article/chapterEnglish2014

Publisher, publication year, extent ...

  • Elsevier BV,2014
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:uu-228962
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-228962URI
  • https://doi.org/10.1016/j.bbmt.2014.03.013DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:129246220URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Non-Hodgkin lymphoma (NHL) disproportionately affects older patients, who do not often undergo allogeneic hematopoietic cell transplantation (HCT). We analyzed Center for International Blood and Marrow Transplant Research data on 1248 patients age >= 40 years receiving reduced-intensity conditioning (RIC) or nonmyeloablative (NMA) conditioning HCT for aggressive (n = 668) or indolent (n = 580) NHL Aggressive lymphoma was more frequent in the oldest cohort 49% for age 40 to 54 versus 57% for age 55 to 64 versus 67% for age >= 65; P = .0008). Fewer patients aged >= 65 had previous autografting (26% versus 24% versus 9%; P = .002). Rates of relapse, acute and chronic GVHD, and nonrelapse mortality (NRM) at 1 year post-HCT were similar in the 3 age cohorts (22% [95% confidence interval (CI), 19% to 26%] for age 40 to 54, 27% [95% CI, 23% to 31%] for age 55 to 64, and 34% [95% CI, 24% to 44%] for age >= 65. Progression-free survival (PFS) and overall survival (OS) at 3 years was slightly lower in the older cohorts (OS: 54% [95% CI, 50% to 58%] for age 40 to 54; 40% [95% CI, 36% to 44%] for age 55 to 64, and 39% [95% CI, 28% to 50%] for age >= 65; P < .0001). Multivariate analysis revealed no significant effect of age on the incidence of acute or chronic GVHD or relapse. Age >= 55 years, Karnofsky Performance Status <80, and HLA mismatch adversely affected NRM, PFS, and OS. Disease status at HCT, but not histological subtype, was associated with worse NRM, relapse, PFS, and OS. Even for patients age >= 55 years, OS still approached 40% at 3 years, suggesting that HCT affects long-term remission and remains underused in qualified older patients with NHL.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Ahn, Kwang Woo (author)
  • Wang, Hai-Lin (author)
  • Antin, Joseph H. (author)
  • Artz, Andrew S. (author)
  • Cahn, Jean-Yves (author)
  • Deol, Abhinav (author)
  • Freytes, Cesar O. (author)
  • Hamadani, Mehdi (author)
  • Holmberg, Leona A. (author)
  • Jagasia, Madan H. (author)
  • Jakubowski, Ann A. (author)
  • Kharfan-Dabaja, Mohamed A. (author)
  • Lazarus, Hillard M. (author)
  • Miller, Alan M. (author)
  • Olsson, RichardKarolinska Institutet,Uppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD)(Swepub:uu)riols677 (author)
  • Pedersen, Tanya L. (author)
  • Pidala, Joseph (author)
  • Pulsipher, Michael A. (author)
  • Rowe, Jacob M. (author)
  • Saber, Wael (author)
  • van Besien, Koen W. (author)
  • Waller, Edmund K. (author)
  • Aljurf, Mahmoud D. (author)
  • Akpek, Goergun (author)
  • Bacher, Ulrike (author)
  • Chao, Nelson J. (author)
  • Chen, Yi-Bin (author)
  • Cooper, Brenda W. (author)
  • Dehn, Jason (author)
  • de Lima, Marcos J. (author)
  • Hsu, Jack W. (author)
  • Lewis, Ian D. (author)
  • Marks, David I. (author)
  • McGuirk, Joseph (author)
  • Cairo, Mitchell S. (author)
  • Schouten, Harry C. (author)
  • Szer, Jeffrey (author)
  • Ramanathan, Muthalagu (author)
  • Savani, Bipin N. (author)
  • Seftel, Matthew (author)
  • Socie, Gerard (author)
  • Vij, Ravi (author)
  • Warlick, Erica D. (author)
  • Weisdorf, Daniel J. (author)
  • Uppsala universitetCentrum för klinisk forskning i Sörmland (CKFD) (creator_code:org_t)

Related titles

  • In:Biology of blood and marrow transplantation: Elsevier BV20:7, s. 960-9681083-87911523-6536

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view